INTRODUCTION
Malaria is a life-threatening disease that is endemic to tropical and subtropical regions (1) . Although Japan is classified as a non-endemic region, travel to malariaendemic regions has resulted in importation of malaria to Japan (2, 3) . Okinawa Prefecture is located in the southernmost part of Japan and is close to Southeast Asia and Oceania, making imported malaria a cause for concern in the prefecture.
The diagnosis and treatment of imported malaria is a clinical challenge in malaria non-endemic areas. Therefore, the main objectives of this study were to evaluate the basic epidemiology of imported malaria in Okinawa and to establish an overall clinical picture in order to make appropriate recommendations to healthcare providers and practitioners in this prefecture.
METHODS
This study was a retrospective chart review and approval was obtained from the Institutional Review Board of the University of the Ryukyus. Malaria patients admitted to the University of the Ryukyus Hospital from 1988 to 2012 were included in this study. Malaria diagnosis was based on microscopic examination of blood smears, immunochromatographic tests for malaria antigen detection, and/or polymerase chain reaction (PCR) detection of malaria-specific DNA (4, 5 
RESULTS
During the study period, 23 malaria cases were admitted to the University of the Ryukyus Hospital. These patients comprised 16 Japanese and 7 foreigners (3 from Africa, 3 from Oceania, and 1 from India). The average age of the patients was 33.2 ± 11.3 years, and the age range was 10-61 years. Male patients comprised 61z of cases, and female patients accounted for 39z of cases.
The types of malaria included Plasmodium falciparum (14 cases), P. vivax (7 cases), combined P. falciparum and P. ovale (1 case), and combined P. vivax and P. malariae (1 case). Malaria diagnosis was based on a blood smear test, antigen rapid detection tests, and PCR (Table 1) ; however, the hospital began using antigen detection tests and PCR only in 1997. PCR detected multiple infections in 2 cases ( Table 1 ). The infections originated in regions such as Africa, Oceania, and Asia (Table 2) .
Intravenous quinine (2 cases) and intravenous artesunate (1 case) were successfully used to treat severe falciparum malaria; this was followed by oral administration of mefloquine (Table 3) . Oral mefloquine, sulfadoxine-pyrimethamine, or chloroquine was used to treat non-severe falciparum malaria. However, treatment with chloroquine resulted in relapse, and another antimalarial drug was then used as salvage therapy. Additionally, hemodialysis was carried out in 2 severe falciparum malaria cases. One of chloroquine, mefloquine, or sulfadoxine-pyrimethamine was used to treat vivax malaria, followed by primaquine treatment (Table  3 ). All cases were resolved without any sequelae. The P. falciparum 8 (1988, 1990, 1991, 1995, 1996, 1996, 1998 P. falciparum ＋ P. ovale 1 (2001) 1
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average length of hospital stays for falciparum malaria and non-falciparum malaria were 19.0 and 10.7 days, respectively. The average hospital stay of the 16 Japanese patients (19.3 days) was longer than that of the 7 foreign patients (8.9 days). Adverse reactions to anti-malarial drugs included vomiting (2 cases with mefloquine), hypoglycemia (1 case with quinine), and liver injury (1 case with sulfadoxine-pyrimethamine). These adverse reactions were mild, and all were resolved. The average interval between arrival in Japan and onset of disease was 36.1 days ( Table 4 ). The interval in falciparum malaria cases (5.2 days) was shorter than that in vivax malaria cases (85.6 days). The longest interval between arrival in Japan and onset of disease was approximately 10 months, which was observed in a case of vivax malaria. The average interval between hospital visit and diagnosis was 1.9 days. The longest interval between hospital visit and diagnosis was 18 days, and this involved the same vivax malaria described case above with the extended incubation period. The average interval between diagnosis and treatment was 0.1 days.
In total, 6 malaria patients had a chemical prophylaxis history (Table 5 ). Among them, 2 appeared to be chloroquine resistant, and treatment with mefloquine was successful. Discontinuation of prophylaxis was noted in 2 cases. No malaria cases with mefloquine prophylaxis were identified.
DISCUSSION
As international transportation has increased, imported malaria has become a significant clinical and public health issue (1-3,6 ). Recent trends have indicated an increase in falciparum malaria cases (6) . Our study describes the status of imported malaria cases in Okinawa Prefecture, Japan and we found that P. falciparum was the most frequently identified strain (15 cases), followed by P. vivax (8 cases). This trend is consistent with the epidemiological data in Japan (2,7) as well as worldwide (1, 6) .
Malaria diagnosis was mainly based on the blood smear findings. However, antigen detection tests were useful for rapid diagnosis of malaria. In addition, PCRconfirmed malaria infection could detect multiple types of malaria (8) . Thus, the availability of these diagnostic tools is important for appropriate diagnosis of future malaria cases in Okinawa.
Treatment for severe falciparum malaria included intravenous administration of quinine or artesunate; this treatment resolved the cases of 2 patients with cerebral malaria and 1 patient with severe falciparum malaria. However, these drugs are not available for public use in Japan. Rather, they are currently supplied by the Japan Research Group on Chemotherapy of Tropical Diseases supported by funds from the Japanese Ministry of Health, Welfare and Labour. Stocking these drugs in Okinawa is of critical importance because the Okinawa islands are a long way from mainland Japan and this makes drug transport to Okinawa difficult in emergency situations. The outcome of malaria treatment is influenced by the immune status of the host (9) . A previous study has demonstrated that non-immune Japanese patients exhibited a worse outcome than immune foreign patients (10) . The present study comprised 16 Japanese and 7 foreigners. All patients survived with anti-malarial drugs and appropriate adjunctive therapy. The average hospital stay of the Japanese patients was longer than that of the foreign patients, suggesting that these 2 patient groups had different immune statuses. This finding supports that of a previous study (10) , but it should be noted that foreign patients do not always have immunity and may develop severe disease.
A delay in diagnosis may be a clinical problem because delayed treatment of malaria can have fatal consequences. In this study, the average interval between hospital visit and diagnosis was less than 2 days. However, 1 P. vivax malaria patient was diagnosed 18 days post-hospital arrival. This patient had traveled to India 10 months earlier, but this travel history was unintentionally neglected in an initial medical assessment. This case reminds us of the value of thorough history taking.
The Okinawa islands were once an endemic area for malaria, and Anopheles mosquitoes, which are the vectors of malaria, still exist in Okinawa. Delay in diagnosis of malaria may be a possible source of secondary malaria infection by infected mosquitoes. Prompt diagnosis of malaria is especially important to prevent autochthonous malaria in Okinawa.
The regional origin of the malaria cases in this study included not only nearby Asia and Oceania, but also Africa. This finding highlights the impact of global transportation on imported malaria cases in Okinawa as well as the rest of Japan (11) and worldwide. Tada et al. (11) demonstrated that Japanese travelers to Papua New Guinea and sub-Saharan countries were exposed to a high risk of malaria. The present study supports their finding. Healthcare providers in Okinawa should be aware of the malaria risk among foreign travelers and prepare for the diagnosis and management of imported malaria cases. This involves stocking the necessary diagnostic and treatment supplies, as well as appropriate collection of travel history data. Additionally, our findings support the need for malaria prophylaxis distribution and adherence among Okinawa residents who travel to malaria-endemic areas.
